Literature DB >> 17437156

Study of efficacy of bilayer mesh device versus conventional polypropelene hernia system in inguinal hernia repair: early results.

Ashutosh Chauhan1, Sangeeta Tiwari, Ashok Gupta.   

Abstract

BACKGROUND: The Prolene hernia system (PHS) is a three-dimensional mesh device that combines three approaches to hernia repair, but its high cost precludes its widespread use in developing countries. We describe our experience with an indigenous bilayer mesh device that works on a similar principle, and compare its efficacy with conventional PHS.
MATERIALS AND METHODS: A total of 84 patients with unilateral/bilateral primary uncomplicated inguinal hernia were recruited for the study over a 1-year period and randomized into two groups. Group 1, which consisted of 40 patients, received the indigenous device, and group 2, 44 patients, received conventional PHS. Mean operative time and the patients' visual assessment scores (VAS) for pain were primary outcome measures. Patient were reviewed in out patients department at intervals of 3 months, and the incidence of complications and recurrence was noted. This was the secondary outcome measure.
RESULTS: The two group were comparable in terms of age, type of hernia, and mean duration of follow-up. The mean operative time was 32.1 min (+/- 5.5) and 33.25 (+/- 5.3) in groups 1 and 2, respectively, and the mean VAS score was 2.25 and 2.27 in the respective groups. There was no statistically significant difference. Similarly, the was no significant difference in incidence of complications noted between the two groups (3/40 versus 4/44, respectively). There were no recurrences noted during the period of observation.
CONCLUSIONS: The indigenous bilayer device described in this study combines the advantages of two well-publicized techniques of hernia repair: inlay repair and onlay repair. It offers the benefits of conventional PHS repair but is far less expensive and is quite suitable for routine use in centers like ours in a developing nation, where financial resources are a constraint.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17437156     DOI: 10.1007/s00268-007-9047-x

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.282


  4 in total

1.  Randomized clinical trial of Lichtenstein patch or Prolene Hernia System for inguinal hernia repair.

Authors:  J Vironen; J Nieminen; A Eklund; P Paavolainen
Journal:  Br J Surg       Date:  2006-01       Impact factor: 6.939

2.  Randomized controlled trial comparing prolene hernia system and lichtenstein method for inguinal hernia repair.

Authors:  Pandanaboyana Sanjay; Dean Harris; Philippa Jones; Alan Woodward
Journal:  ANZ J Surg       Date:  2006-07       Impact factor: 1.872

3.  The tension-free hernioplasty.

Authors:  I L Lichtenstein; A G Shulman; P K Amid; M M Montllor
Journal:  Am J Surg       Date:  1989-02       Impact factor: 2.565

4.  Tension-free mesh hernia repair: review of 1098 cases using local anaesthesia in a day unit.

Authors:  A E Kark; M Kurzer; K J Waters
Journal:  Ann R Coll Surg Engl       Date:  1995-07       Impact factor: 1.891

  4 in total
  4 in total

Review 1.  Low-cost mesh for inguinal hernia repair in resource-limited settings.

Authors:  J Yang; D Papandria; D Rhee; H Perry; F Abdullah
Journal:  Hernia       Date:  2011-05-24       Impact factor: 4.739

Review 2.  The use of sterilized mosquito nets for hernioplasty: a systematic review.

Authors:  C G Sørensen; J Rosenberg
Journal:  Hernia       Date:  2012-08-03       Impact factor: 4.739

Review 3.  A detailed analysis of outcome reporting from randomised controlled trials and meta-analyses of inguinal hernia repair.

Authors:  A Bhangu; P Singh; T Pinkney; J M Blazeby
Journal:  Hernia       Date:  2014-08-12       Impact factor: 4.739

4.  Meta-analysis of the use of sterilized mosquito net mesh for inguinal hernia repair in less economically developed countries.

Authors:  M H Ahmad; S Pathak; K D Clement; E H Aly
Journal:  BJS Open       Date:  2019-02-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.